Animal study · mice
FOXO4-DRI improved sperm quality in naturally aged mice
Checked against the paper Animal studyPublished by PepVault
The takeaway
This adds early mouse and cell evidence that FOXO4-DRI may help sperm production in aging males, but it has not been shown in humans.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2024
- Journal
- Exp Gerontol
What they tested
The team tested whether FOXO4-DRI could clear senescent Leydig cells and improve sperm production in aging males.
How the study was done
A lab study with two parts. Senescent (aged, no longer dividing) Leydig cells were treated with FOXO4-DRI and grown together with GC-1 SPG cells, and naturally aged mice were given FOXO4-DRI.

What they found
In cell experiments, FOXO4-DRI caused apoptosis (programmed cell death) in senescent Leydig cells. It also cut the release of some senescence-associated secretory phenotype factors, the substances senescent cells give off. GC-1 SPG cells grown alongside the treated cells multiplied better. In naturally aged mice, treated animals had better sperm quality and improved spermatogenesis (sperm production).
What it doesn’t show
This work was done in mice and lab-grown cells, not in people. It does not show whether fertility or sperm measures would change in aging men.
The paper
Li et al. FOXO4-DRI improves spermatogenesis in aged mice through reducing senescence-associated secretory phenotype secretion from Leydig cells. Exp Gerontol. 2024.
The compound
More studies on FOXO4-DRI
- FOXO4-DRI eased age-related testosterone shortfall in aged miceAnimal study · mice · 2020
- FOXO4-DRI raised cell death in lab-grown keloid fibroblastsCell study · human keloid fibroblasts · 2025
- FOXO4-DRI cleared senescent cells from expanded human chondrocytesCell study · human chondrocytes · 2021
- Every study on FOXO4-DRI
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.